Alnylam Announces Planned CEO Leadership Transition
Go back to Alnylam Announces Planned CEO Leadership Transition| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 232.88 -9.73 (4.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $242.61 | 52 Week High | $109.10 | |||
| Open | $239.00 | 52 Week Low | $31.38 | |||
| Day High | $240.88 | P/E | N/A | |||
| Day Low | $232.33 | EPS | $-1.45 | |||
| Volume | 846,291 | |||||

